Results 81 to 90 of about 13,305 (212)

Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross‐Sectional Study

CNS Neuroscience &Therapeutics, Volume 32, Issue 8, August 2026.
The disease severity of adult myasthenia gravis is influenced by multiple factors. Our results showed that gender, age at onset, BMI, onset symptoms, thymoma, and thymectomy were correlated with disease scores. Additionally, environmental exposures, including latitude, altitude, sunlight duration, PM2.5, education, and monthly household income, also ...
Haoran Liu, Jingsi Wang, Wenjia Zhu, Ting Chang, Hongxi Chen, Chao Sun, Rongjing Guo, Zhe Ruan, Fangfang Bi, Jing Li, Jianwen Wang, Shu Zhang, Qi Wen, Yaye Wang, Yun Li, Nairong Xie, Yuting Jiang, Yan Lu, Li Di, Min Xu, Min Wang, Hai Chen, Xinmei Wen, Jianying Duo, Yue Huang, Huiyu Feng, Hongyu Zhou, Yuwei Da   +27 more
wiley   +1 more source

Myasthenia. Surgical treatment and its effectiveness

Acta Biomedica Scientifica, 2012
The article reviews the problems of diagnostics and. treatment of myasthenia. The authors consider that thymectomy in modern conditions is founded, expedient and. safe for the patients surgery at the treatment of different forms of myasthenia.
M. B. Skvortsov, A. I. Smolin
doaj  

Descriptive analysis of therapeutic outcomes between thoracoscopic and transsternal thymectomy in myasthenia gravis patients from 2011 to 2021

Journal of Cardiothoracic Surgery
Background Myasthenia gravis is an autoimmune disease with high prevalence of thymus disorders, in which, thymectomy is considered one of the therapeutic approaches in improving the patients’ clinical outcomes.
Mahdiye Lashkarizadeh, Vahid Haghollahi, Nazanin Zeinali Nezhad, Mohammadreza Lashkarizadeh, Amirhossein Shahpar   +4 more
doaj   +1 more source

Ofatumumab Treatment for Refractory Generalized Myasthenia Gravis Post‐Lung Adenocarcinoma Resection: A Case Report and Mechanistic Insight

Immunity, Inflammation and Disease, Volume 14, Issue 8, August 2026.
ABSTRACT Background Myasthenia gravis (MG), an autoimmune neuromuscular disorder, may rarely coexist with malignancies such as lung cancer. Case Presentation This case report presents the first documented use of ofatumumab, a fully human anti‐CD20 monoclonal antibody, in a 75‐year‐old female with acetylcholine receptor (AChR)‐antibody‐positive ...
Xia Long, Yanwen Xu, Juan Xiong, Wenfeng Peng, Jinhua Qiu, Yanxia Zhou   +5 more
wiley   +1 more source

Effect of pregnancy and birth on the course of myasthenia gravis before or after transsternal radical thymectomy [PDF]

, 2006
OBJECTIVE: Myasthenia gravis (MG) affects women at childbearing age. Therefore, the question arises if these patients should become pregnant and if thymectomy has a positive effect on the course of MG in pregnant patients.
Raths, Janine, Carboni, Gianluca, Schmid, Ralph Alexander, Roth, Thierry Christophe, Rösler, Kai   +4 more
core   +2 more sources

Non‐Cyclic Rozanolixizumab Administration in Complex Generalized Myasthenia Gravis

Muscle &Nerve, Volume 74, Issue 2, Page 422-426, August 2026.
ABSTRACT Introduction/Aims Rozanolixizumab, an inhibitor of the neonatal Fc receptor (FcRn), is used to treat patients with generalized myasthenia gravis (gMG) refractory to standard therapies. However, the approved six‐week cyclic regimen may be associated with a “wearing‐off” effect and disease fluctuations. We evaluated the non‐cyclic administration
Marc Abi Aoun, Diane Beauvais, Marlène Barnay, Marie‐Hélène Violleau, Stéphane Mathis, Fanny Duval, Guilhem Sole   +6 more
wiley   +1 more source

Prognostic Factors for Postoperative Complications. An Aggregate Protocol for 10 Observational Studies From the Danish TRIPLE‐A Cohort of 1.2 Million Surgeries

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 7, August 2026.
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen, Asta Prescott, Caroline Folkersen, Jens Laigaard, Atena Saito, Caroline Lando Klammer, Mik Wetterslev, Emil Ipsen Ørskov, Mathilde Fahrendorff, Rebecca Kiær, Helene Holm Laigaard, Nichlas Hovmand, Lars Hyldborg Lundstrøm, Sebastian Buhl Rasmussen, Anders Kehlet Nørskov, Markus Harboe Olsen   +15 more
wiley   +1 more source

Extended videothoracoscopic thymectomy in nonthymomatous myasthenia gravis

, 2010
Myasthenia gravis (MG) is an uncommon, organ-specific, autoimmune chronic neuromuscular disorder involving the production of autoantibodies directed against the nicotinic acetylcholine receptors (anti-AchRab).
MINEO, TOMMASO CLAUDIO, Mineo, TC, Pompeo, E, POMPEO, EUGENIO   +3 more
core   +1 more source

Thymic hyperplasia as a rare etiology of pure red cell aplasia: A case report [PDF]

Vojnosanitetski Pregled
Introduction. Thymic hyperplasia is a rare condition caused by an increase in cellular thymic mass and, in some cases, is associated with autoimmune diseases, such as pure red cell aplasia (PRCA).
Arsenović Isidora, Leković Danijela, Šefer Dijana, Pavlović Miroslav, Ivanović Jelena, Smiljanić Mihailo, Bogdanović Andrija   +6 more
doaj   +1 more source

Robotic thymectomy for myasthenia gravis

, 2020
Thymectomy is an effective treatment option for the management of myasthenia gravis, as demonstrated by a recent multicenter randomized clinical trial.
Faccioli, Eleonora, Rossi, Sara, Rea, Federico, Mammana, Marco, Comacchio, Giovanni M., De Franceschi, Elisa, Dell’Amore, Andrea   +6 more
core